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Abstract Hypertrophic cardiomyopathy is characterised by a
histological phenotype of myocyte disarray, but heart tissue
samples from patients with dilated cardiomyopathy (DCM)
often look comparatively similar to those from healthy indi-
viduals apart from conspicuous regions of fibrosis and necro-
sis. We have previously investigated subcellular alterations in
the cytoarchitecture of mouse models of dilated cardiomyop-
athy and found that both the organisation and composition of
the intercalated disc, i.e. the specialised type of cell–cell
contact in the heart, is altered. There is also is a change in
the composition of the M-band of the sarcomere due to an
expression shift towards the more extensible embryonic heart
(EH)-myomesin isoform. Analysis of human samples from
the Sydney Human Heart Tissue Bank have revealed similar
structural findings and also provided evidence for a dramatic
change in overall cardiomyocyte size control, which has also
been seen in the mouse. Together these changes in
cytoarchitecture probably contribute to the decreased func-
tional output that is seen in DCM.
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In human heart disease the heart changes in one of two ways,
either hypertrophy or dilation (Seidman and Seidman 2001).
In hypertrophic cardiomyopathy (HCM), the walls of the
ventricle thicken, which leads to a restricted chamber volume.
HCM is usually identified histologically by a marked pattern
of myocyte disarray in addition to fibrosis. HCM is addition-
ally characterised by the re-expression of a set of marker genes
that are usually not detectable in the postnatal heart, including
those for atrial natriuretic peptide (ANP) and brain natriuretic
peptide (BNP) or of the embryonic isoforms of, for example,
contractile proteins such as myosin and actin (MacLellan and
Schneider 2000; Copeland et al. 2010).
In dilated cardiomyopathy (DCM), the heart balloons and
the chamber volume increases (Seidman and Seidman 2001).
This condition can be accompanied by a thinning of the ven-
tricular wall. The heart tissue of DCM patients can have an
apparently normal appearance at the histological level, with
nicely arranged strands of myocytes running in parallel.
While there are areas of necrosis and fibrosis, often the majority
of the tissue looks comparatively normal, thereby providing no
good explanation for the dramatic failure in function that is seen
at the physiological level. To date, only a very limited number
of molecular markers specific for DCM have been defined.
Alterations at the cellular level in mouse models of dilated
cardiomyopathy
Our research group initially set out to explore potential alter-
ations at the cellular level in DCM by employing mouse
models of this disease (for a schematic representation of a
single cardiomyocyte and its main structural components, see
Fig. 1). In a first study, we used the MLP knockout mouse,
which is the first genetically modified mouse model of DCM
(Arber et al. 1997). We then went on to confirm our observa-
tions in a tropomodulin-overexpressing transgenic mouse
(Sussman et al. 1998) and in a mouse that expressed a non-
degradable version of the adherens junction protein beta-
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catenin (Hirschy et al. 2010). These studies focussed on the
expression and localisation of different cytoskeletal proteins
in the specialised type of cell–cell contacts found in the heart
(intercalated discs) or in myofibrils. At the intercalated discs
we saw a dramatic upregulation of proteins that anchor the
sarcomeric actin filaments. Cytoplasmic components of the
adherens junctions, such as beta-catenin and plakoglobin and
their transmembrane counterpart, the catenins, were upregulat-
ed, contributing to an increased width of signal at the interca-
lated disc, as observed by immunohistochemistry and confocal
microscopy (Ehler et al. 2001). The expression levels of des-
mosomal proteins were unchanged, but the levels of connexin-
43, a component of the gap junctions involved in ion transfer
between cardiomyocytes, were reduced. We also detected
increased expression of nebulin-related anchoring protein
(NRAP) and formin-homology-domain-containing protein 1
(FHOD1). Both are located at the intercalated disc, and the
latter is a member of the formin family of regulators of actin
filament formation (Ehler et al. 2001; Dwyer et al. 2014). The
increased width at the intercalated disc seen by light micros-
copy following staining for actin-associated proteins was ex-
plained as an increased degree of membrane convolution, as
has also been seen in ultrastructural analysis (Ehler et al. 2001).
Most sarcomeric proteins, such as alpha-actinin (a compo-
nent of the Z-disc), myomesin (a component of the M-band)
and thin and thick filament proteins [cardiac actin, sarcomeric
myosin or MyBP-C (muscle protein myosin binding protein
C)] do not alter their expression levels or their localisation
patterns in DCM (Ehler et al. 2001). Schoenauer et al. (2011)
observed a shift in isoform expression of myomesin towards
the expression of EH (embryonic heart)-myomesin, which is
usually predominant only in the embryonic heart muscle and
in slow muscle. The myomesin molecule is made up almost
exclusively of immunoglobulin and fibronectin type III
domains (Agarkova et al. 2000), similar to other myosin
binding proteins, such as MyBP-C and titin. EH-myomesin
has an insertion of a domain in the middle of the myomesin
molecule that appears to function in an analogous way to the
PEVK domain of titin and displays more elastic properties in
biophysical assays (Schoenauer et al. 2005). The composition
of the M-band can be correlated to muscle type and develop-
mental stage (Agarkova and Perriard 2005), and it has been
speculated that this more extensible domain in EH-myomesin
may be required for the function of myofibrils that have not
perfectly aligned thick filaments, such as in the embryonic
heart (Manasek 1968; Agarkova and Perriard 2005). In DCM,
a similar switch in expression to a more extensible, embryonic
isoform of a protein has been reported for titin (Makarenko
et al. 2004), an elastic filament protein that spans all the way
from the Z-disc to the M-band.
Can similar changes be observed in samples from human
patients with dilated cardiomyopathy?
Since inbred mouse strains are not necessarily representative
of the heterogenous human population, the aim of our research
group for several years has been to try to determine whether
similar cytoskeletal alterations can also be seen in human
hearts from DCM patients using samples from the Sydney
Human Heart Tissue Bank that had always been stored in
liquid nitrogen. Different types of DCM, as classified by the
clinicians, were analysed in these studies, including idiopathic
DCM (IDCM), familial DCM (FDCM) and DCM following a
viral infection (VDCM).
Our initial analysis of different human DCM samples by
immunohistochemistry followed by confocal microscopy re-
vealed an increase in size distribution when the outlines of the
Fig. 1 Schematic representation of an isolated adult cardiomyocyte. The
regions of cell–cell contact, i.e. the intercalated discs, are situated at both
ends of the cell. The cytoplasm is filled with myofibrils (just one shown
here), which are arranged in a paracrystalline fashion and have
sarcomeres which stretch between two Z-discs as the basic unit. Actin
and its associated proteins (thin filaments, yellow) are found in the I-band,
and myosin and its associated proteins (thick filaments, dark blue) are
found in the A-band. One titin molecule (elastic filaments, red) stretches
from the Z-disc to theM-band (shown inmagenta), which is in the middle
of each sarcomere and links the elastic filament system with the myosin
filaments. The transitional junction (TrJ) is a proposed site for insertion of
new sarcomeres in the region of the intercalated disc. At the sides the
myofibrils are linked at Z-disc level with the surrounding extracellular
matrix by structures called costameres
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cardiomyocytes were delineated by staining for beta-catenin
and laminin. The traditional assumption is that DCM is caused
by a general elongation of the cardiomyocytes that is accom-
panied by their slippage, leading to a thinning of the ventric-
ular wall . Our measurements showed that while
cardiomyocytes from non-failing hearts showed relatively
little variability in size, diameter or length, cardiomyocytes
from DCM patients of different etiologies were always
characterised by an increased variation in these parameters
(Fig. 2; Table 1). These findings mirror our initial studies on
mouse models of DCM where we saw more variability in
size—and not necessarily just elongation—of the
Fig. 2 Analysis of size
parameters of non-failing healthy
cardiomyocytes and failing
cardiomyocytes in dilated cardio-
myopathy (DCM). Failing
(DCM) cardiomyocytes show a
larger range of measurements, in-
dicating a departure from the
usually narrow distribution of
physiological size. Cell dimen-
sions were obtained from confo-
cal micrographs of longitudinally
sections of cardiomyocytes
stained with antibodies against
beta-catenin and laminin to delin-
eate the cell borders and
myomesin. Horizontal lines
Means, error bars standard devi-
ations (SD), grey symbols indi-
vidual measurements to show
range and distribution. IDCM Id-
iopathic DCM, FDCM familial
DCM, VDCM viral-caused DCM
Table 1 Length, width and area of non-failing control heart cardiomyocytes and cardiomyocytes in dilated cardiomyopathy
Measurea Control (n=80) IDCM (n=42) FDCM (n=14) VDCM (n=42) all DCM (n=98)
Maximum length (μm) 124.0 170.0 196.0 210.0 210.0
Minimum length (μm) 51.6 41.1 39.4 35.1 35.1
Range (μm) 72.5 128.9 156.6 174.9 174.9
Average length (μm) 90.4 102.7 100.2 91.0 93.2
Maximum width (μm) 39.7 30.6 20.4 52.5 52.5
Minimum width (μm) 12.3 11.4 9.9 12.2 9.9
Range (μm) 27.4 19.2 10.5 40.3 42.6
Average width [μm] 19.8 19.0 15.2 26.4 20.9
Maximum area (μm2) 2850.5 4060.0 3626.0 4268.4 4268.4
Minimum aera (μm2) 956.3 762.4 502.9 428.2 428.2
Range (μm2) 1894.2 3297.6 3123.1 3840.2 3840.2
Average area (μm2) 1756.3 2017.0 1643.3 2290.8 1937.4
DCM Dilated cardiomyopathy, IDCM idiopathic DCM, FDCM familial DCM, VDCM viral-caused DCM
aNon-failing and DCM heart sample sections were stained for laminin and beta-catenin to delineate the cell borders and myomesin for cardiomyocyte
identification. The slides were co-stained with DAPI to indicate nuclei, and individual cells were measured at the nucleus level using LAS AF Lite
software (Leica Microsystems, Wetzlar, Germany)
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cardiomyocytes (Leu et al. 2001; Hirschy et al. 2010). These
observations suggest that the thinner wall of the DCM ventri-
cle cannot always be explained solely by longer cells and that
during the course of the disease cardiomyocytes lose some
degree of size control. The signalling pathways which control
cardiomyocyte growth are not very well understood at present
(Földes et al. 2011).
When intercalated disc composition was analysed, we
again observed increased protein levels for plakoglobin at
the intercalated discs of the failing (DCM) patients compared
to the non-failing controls (Fig. 3). This protein is found in
adherens junctions, which anchor actin filaments, and in des-
mosomes, which anchor intermediate filaments. The concept
that these two types of cell–cell contacts are clearly separated
in cardiomyocytes has been recently challenged by the pro-
posal of the “area composita”, demonstrated in the hearts of a
variety of species, including humans (Franke et al. 2006).
Interestingly, in samples from failing human hearts, a consis-
tent downregulation of connexin-43 expression is not found:
in some patients it is reduced, while in others the levels are
comparable to those found in non-failing tissue (Pluess and
Ehler, manuscript in preparation). At present it is unclear why
failing (DCM) cardiomyocytes in humans respond differently
to those in mice, but the effects of patient medication on
connexin-43 expression cannot be excluded.
We found the general arrangement of sarcomeric proteins
to be unaffected in both human and mouse DCM samples. As
can be appreciated from the localisation pattern for titin or
myomesin shown in Figs. 3 and 4, the cross-striations resem-
ble those of the controls, i.e. there is not much evidence of
dramatic myofibril disarray. Similar to the mouse, re-
expression of EH-myomesin was also detected in human
DCM hearts (Fig. 4). Upregulation of the expression of this
embryonic isoform was seen in some cardiomyocytes and not
Fig. 3 Increased signal for plakoglobin at the intercalated disc of DCM
tissue samples. Confocal micrographs of cryosections from non-failing
(healthy; NF) control and failing hearts (DCM). The intercalated discs
were stained with monoclonal mouse antibodies against plakoglobin (red
signal in overlay), the myofibrils were stained with polyclonal rabbit
antibodies against the titin m8 epitope (green signal in overlay) and the
nuclei were visualised with DAPI (blue signal in overlay). An increased
width of signal for plakoglobin is apparent at the intercalated discs from
tissue samples of different DCM patients compared to tissue from
control (healthy) patients (arrowheads). A signal at the lateral
edges of the cardiomyocytes can be occasionally detected in
DCM (arrow)
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in others. We made use of a tissue array with different cardio-
myopathy samples and stained it for EH-myomesin expres-
sion. Analysis of the extent of expression revealed that there
was a good correlation between high expression and IDCM
and FDCM, but that lower expression of EH-myomesin
occurred in HCM and non-failing hearts (Fig. 5). This
makes EH-myomesin a potential marker for DCM.
However, it must be noted that EH-myomesin is also
expressed in the conduction system of the heart, partic-
ularly in the interventricular septum (Meysen et al.
2007); therefore it is important to note the location in
the ventricle where the samples are taken.
Approximately 25 % of cases of FDCM are caused by
truncation of the titin gene (Herman et al. 2012). Next gener-
ation sequencing (NGS) of FDCM in the samples in the
Sydney Human Heart Tissue Bank has commenced only
Fig. 4 The more extensible, embryonic isoform of the M-band protein
myomesin (EH-myomesin) is re-expressed in a cell-autonomous manner
in DCM. Confocal micrographs of cryosections from non-failing healthy
and DCM hearts. The M-bands were stained with monoclonal mouse
antibodies against myomesin (red signal in overlay), the EH-myomesin
isoform was stained with polyclonal rabbit antibodies against the human
EH domain (green signal in overlay) and the nuclei were visualised with
DAPI (blue signal in overlay). While no green signal can be detected in
the healthy human heart, individual cardiomyocytes show a re-expression
of EH-myomesin
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recently, and no results have yet been published. Fürst et al.
(1988) reported a monoclonal antibody (clone T12) against
the N-terminal region of titin that recognises an epitope at the
edge of the Z-disc, and Obermann et al. (1996) located a
polyclonal antibody against the C-terminal titin m8 domain
at the M-band. In all of the samples we have analysed to date,
these two antibodies have revealed clear alterations of titin
striations at apparently similar levels of intensity throughout
the section (Fig. 6 and unpublished data). This result is sur-
prising, since our expectation was fainter staining for the C-
terminal epitope in some of the samples if they originated
from patients with a truncated titin. However, since we cur-
rently have no NGS information on the genetic status of the
samples used in our studies, we do not know whether these
patients carry mutations in the titin gene that would lead to a
truncated protein. Another complication of this research is that
mutant titin may not necessarily be expressed at the expected
ratio, which is 50% since all the patients will be heterozygous.
In the case of MyBP-C, truncating mutations can also cause
HCM, and for this disease a haploinsufficiency mechanism
has been proposed (Marston et al. 2009). Truncated MyBP-C
has never been detected at the protein level, leading to the
proposal that nonsense-mediated decay of the mRNA pre-
vents its production (van Dijk et al. 2009) and may even
prevent the translation in cases of point mutations in
MyBP-C (Vignier et al. 2009). Mutations in other sarcomeric
proteins, such as myosin, are not expressed at the expected
50 % ratio, but can be expressed at variable levels between
patients and even between cardiomyocytes (Tripathi et al.
2011). The first report on a titin mutation causing DCM did
show the existence of a truncated titin protein (Gerull et al.
2002). However, no biochemical analysis of titin has been
carried out on the DCM samples available to us to date.
Dilated cardiomyopathy: From cellular to functional
phenotype?
What are the functional consequences of the changes that we
observed in the DCM samples from mice and (wo)men? The
higher variability in cell size will obviously affect the three-
dimensional composition of the heart tissue and may be one of
the explanations why we see these alterations in the cell–cell
contact sites, i.e. the intercalated discs (for schematic represen-
tation of changes in DCM see Fig. 7). Suboptimal co-ordination
between cell size and force per cell may necessitate an increase
Fig. 5 EH-myomesin expression is increased in IDCM and FDCM
compared to HCM and healthy tissue samples. Quantification of pixel
intensity from a tissue array containing 108 tissue spots for 54
individuals, stained with anti-human EH-myomesin antibodies and
analysed by confocal microscopy. The values were grouped according
to the underlying disease. A median of the weighted averages was
determined for each subgroup: IDCM = 41.6; FDCM = 40.4; HCM =
28.1; non-failing healthy controls = 22.2
Fig. 6 The titin T12 and m8 epitopes are stained with equal intensity in
longitudinal sections of different DCM samples. Confocal micrographs of
cryosections from non-failing (healthy; NF) and DCM hearts. The T12
epitope of titin in the Z-disc region was stained with monoclonal mouse
antibodies (red signal). The m8 epitope of titin was stained with poly-
clonal rabbit antibodies (green signal) at theM-band. The Sydney Human
Heart Tissue Bank patient codes are indicated. Scale bar: 2 μm
Fig. 7 Schematic representations of the alterations at the level of the
heart tissue (a) and the cardiomyocyte (b) in healthy and DCM hearts. a
While the alignment of the cardiomyocytes is not greatly affected in
DCM, there are patches of fibrosis (yellow) and a wider variation in cell
size that lead to impaired coupling between cardiomyocytes. A subset of
the cardiomyocytes (darker colour) re-express EH-myomesin. b The
membrane at the intercalated discs is more convoluted in DCM
cardiomyocytes. This is accompanied by an increased presence of actin
anchoring adherens junctions (blue). The alignment of the myofibrils is
unaffected, but there is an isoform shift in myomesin expression of the
more extensible EH-myomesin at the M-band (darker striations)
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in actin anchorage to prevent tissue disintegration during con-
traction. It remains to be seen whether the formin FHOD1,
detected at elevated levels at the intercalated discs of DCM in
mice and humans (Dwyer et al. 2014), is responsible for the
increased actin filament formation. The importance of the
proper stoichiometry of expression of adherens junction protein
resulting in heart failure has been reviewed elsewhere (Perriard
et al. 2003; Vite and Radice 2014). NRAP is the first reported
protein to be upregulated in the course of DCM (Ehler et al.
2001). Transgenic mice that overexpress this protein have
dilated hearts and develop right ventricular dysfunction (Lu
et al. 2011). The composition of the intercalated disc is impor-
tant because it is the major site for the insertion of new sarco-
meres during growth of the adult heart (Yoshida et al. 2010). In
DCM hearts, this otherwise carefully regulated process leads to
altered “step sizes” between the cells that no longer follow the
“one step amounts to the length of one sarcomere” rule (Wilson
et al. 2014). These irregularities are probably the basis for the
increased degree of membrane convolution that is seen in the
DCM heart and has also been reported for the aged heart
(Forbes and Sperelakis 1985; Ehler et al. 2001). Other potential
consequences of irregular tissue composition are fibrosis and
changes in intercalated disc architecture that lead to an in-
creased risk of arrhythmic events. Reduced expression of the
gap junction protein connexin-43, as observed in all mouse
models of DCM and a subset of the human patients, will impair
intercellular communication and thus interfere with the efficient
propagation of stimuli that produce contraction. In addition,
lateral deposition of proteins such as plakoglobin and
erroneous lateral gap junctions will contribute to a more
arrhythmogenic phenotype (Severs et al. 2008).
The general composition of the myofibrils and arrangement
of sarcomeres seems to be little affected in DCM, andmyofibril
disarray also appears to be minimal. There may be a failure in
myofibril maintenance, which will eventually lead to shrinking
of the cardiomyocytes or necrosis. For example, we correlated
decreased expression levels of another formin, the muscle
isoform of FHOD3, with human heart failure (Iskratsch et al.
2010). The composition of the M-band of the sarcomere is
changed and reverts to a more embryonic phenotype. At pres-
ent it is unclear whether the cell autonomous re-expression of
EH-myomesin is beneficial. Schoenauer et al. (2011) reported
that high EH-myomesin levels are correlated with a decrease in
cardiac function in human samples. On the other hand, the
initial reversion to embryonic phenotypes of myomesin and
titin isoforms may be an adaptation to cope with increased
mechanical stress. In the human samples we examined higher
expression levels of EH-myomesin correlated with a
longstanding disease and a low ejection fraction (Pluess and
Ehler, manuscript in preparation).
The above observations point to the complimentary nature
of the interactions of titin andmyomesin and provide plausible
explanations for the changes observed in DCM heart failure.
In summary, alterations that are seen at the level of tissue
composition and in the arrangement of the cytoskeleton of
cardiomyocytes appear to contribute to the functional changes
that are seen at the level of physiology.
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